SequelSEC

BRISTOL MYERS SQUIBB CO BMY

Pharmaceutical Preparations · CIK 0000014272 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$49.19B
Fiscal year ended 2026-06-30
Operating income
Unavailable
Fiscal year ended 2026-06-30
Free cash flow
$11.44B
Fiscal year ended 2026-06-30

BRISTOL MYERS SQUIBB CO (BMY) reported revenue of $49.19B and net income of $9.28B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BRISTOL MYERS SQUIBB CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

BRISTOL MYERS SQUIBB CO income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$49.19B
Cost of revenue$14.68B
Gross profit$34.51B
Operating incomeUnavailable
Net income$9.28B
Research & development$10.72B
Weighted-average diluted sharesUnavailable
Pretax income$11.91B
Income tax expense$2.63B
Diluted EPSUnavailable
Selling, general & administrative$7.41B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

BRISTOL MYERS SQUIBB CO balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$8.72B
Total assets$87.63B
Current assets$28.58B
Total liabilities$65.32B
Current liabilities$18.66B
Total equity incl. NCI$22.32B
Temporary (mezzanine) equityUnavailable
Inventory$2.74B
Accounts receivable$9.08B
Goodwill$21.74B
Long-term debt$42.09B
Accounts payable$4.16B

Cash flow

BRISTOL MYERS SQUIBB CO cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$12.78B
Capital expenditures$1.34B
Investing cash flow-$4.90B
Financing cash flow-$11.71B
Net change in cash-$3.89B
Stock-based compensation$553.00M
Common dividends paid$5.10B
Common share repurchasesUnavailable
Depreciation & amortization$3.18B

Derived

BRISTOL MYERS SQUIBB CO derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$11.44B
Gross margin70.2%
Operating marginUnavailable
FCF margin23.3%
SBC / revenue1.1%
Current ratio1.53x
Revenue YoY growth3.1%
Net margin18.9%
R&D / revenue21.8%
CapEx / revenue2.7%
Long-term debt / equity1.89x
Effective tax rate22.1%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BMY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-04-24View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.